These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 7958489)
1. Transgenic approaches to the pathogenesis of NIDDM. Moller DE Diabetes; 1994 Dec; 43(12):1394-401. PubMed ID: 7958489 [TBL] [Abstract][Full Text] [Related]
2. Genetic manipulation of insulin signaling, action and secretion in mice. Insights into glucose homeostasis and pathogenesis of type 2 diabetes. Baudry A; Leroux L; Jackerott M; Joshi RL EMBO Rep; 2002 Apr; 3(4):323-8. PubMed ID: 11943762 [TBL] [Abstract][Full Text] [Related]
3. The genetics of human noninsulin-dependent (type 2) diabetes mellitus. Elbein SC J Nutr; 1997 Sep; 127(9):1891S-1896S. PubMed ID: 9278577 [TBL] [Abstract][Full Text] [Related]
4. Non-insulin-dependent diabetes mellitus--a collision between thrifty genes and an affluent society. Groop LC; Tuomi T Ann Med; 1997 Feb; 29(1):37-53. PubMed ID: 9073323 [TBL] [Abstract][Full Text] [Related]
5. On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Current controversies and new insights. Vaag A Dan Med Bull; 1999 Jun; 46(3):197-234. PubMed ID: 10421979 [TBL] [Abstract][Full Text] [Related]
6. Are animal models of diabetes relevant to the study of the genetics of non-insulin-dependent diabetes in humans? Ktorza A; Bernard C; Parent V; Penicaud L; Froguel P; Lathrop M; Gauguier D Diabetes Metab; 1997 Mar; 23 Suppl 2():38-46. PubMed ID: 9105782 [TBL] [Abstract][Full Text] [Related]
7. Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes. Devedjian JC; George M; Casellas A; Pujol A; Visa J; Pelegrín M; Gros L; Bosch F J Clin Invest; 2000 Mar; 105(6):731-40. PubMed ID: 10727441 [TBL] [Abstract][Full Text] [Related]
8. Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research. Polonsky KS Diabetes; 1995 Jun; 44(6):705-17. PubMed ID: 7789637 [TBL] [Abstract][Full Text] [Related]
9. Cellular engineering and gene therapy strategies for insulin replacement in diabetes. Newgard CB Diabetes; 1994 Mar; 43(3):341-50. PubMed ID: 8314006 [TBL] [Abstract][Full Text] [Related]
10. Lessons from transgenic and knockout animals about noninsulin-dependent diabetes mellitus. Patti ME; Kahn CR Trends Endocrinol Metab; 1996 Nov; 7(9):311-9. PubMed ID: 18406764 [TBL] [Abstract][Full Text] [Related]
11. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Garvey WT; Maianu L; Hancock JA; Golichowski AM; Baron A Diabetes; 1992 Apr; 41(4):465-75. PubMed ID: 1535055 [TBL] [Abstract][Full Text] [Related]
12. Genetically engineered mice as animal models for NIDDM. Joshi RL; Lamothe B; Bucchini D; Jami J FEBS Lett; 1997 Jan; 401(2-3):99-103. PubMed ID: 9013866 [TBL] [Abstract][Full Text] [Related]